|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS CONTAINED IN THE COMPANY'S QUARTERLY
REPORT ON FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 160
<SECURITIES> 1,707
<RECEIVABLES> 325
<ALLOWANCES> 21
<INVENTORY> 294
<CURRENT-ASSETS> 2,622
<PP&E> 2,620
<DEPRECIATION> 905
<TOTAL-ASSETS> 4,898
<CURRENT-LIABILITIES> 723
<BONDS> 223
0
0
<COMMON> 0
<OTHER-SE> 3,952
<TOTAL-LIABILITY-AND-EQUITY> 4,898
<SALES> 2,355
<TOTAL-REVENUES> 2,678
<CGS> 297
<TOTAL-COSTS> 297
<OTHER-EXPENSES> 595<F1>
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 12
<INCOME-PRETAX> 1,354
<INCOME-TAX> 427
<INCOME-CONTINUING> 928
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 928
<EPS-BASIC> 0.90
<EPS-DILUTED> 0.86
<FN>
<F1>ITEM CONSISTS OF RESEARCH AND DEVELOPMENT EXPENSES.
</FN>
</TABLE>
|
|